Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis - Huang, Ni; Perez, Paola; Kato, Takafumi; Mikami, Yu; Okuda, Kenichi; Gilmore, Rodney C.; Domínguez Conde, Cecilia; Gasmi, Billel; Stein, Sydney; Beach, Margaret; Pelayo, Eileen; Maldonado, Jose; et al. (medRxiv, 2020)
Despite signs of infection, the involvement of the oral cavity in COVID-19 is poorly understood. To address this, single-cell RNA sequencing data-sets were integrated from human minor salivary glands and gingiva to identify 11 epithelial, 7 mesenchymal, and 15 immune cell clusters. Analysis of SARS-CoV-2 viral entry factor expression showed enrichment in epithelia including the ducts and acini of the salivary glands and the suprabasal cells of the mucosae. COVID-19 autopsy tissues confirmed in vivo SARS-CoV-2 infection in the salivary glands and mucosa. Saliva from SARS-CoV-2-infected individuals harbored epithelial cells exhibiting ACE2 expression and SARS-CoV-2 RNA. Matched nasopharyngeal and saliva samples found distinct viral shedding dynamics and viral burden in saliva correlated with COVID-19 symptoms including taste loss. Upon recovery, this cohort exhibited salivary antibodies against SARS-CoV-2 proteins. Collectively, the oral cavity represents a robust site for COVID-19 infection and implicates saliva in viral transmission.Competing Interest StatementIn the last year KMB has been a Scientific Advisor at Arcato Laboratories, Inc. and Coordinator at the Human Cell Atlas. For the last month MOF has served as a Scientific Advisor for PolyBio Research Foundation. In the last 3 years SAT has been remunerated for consulting by Roche and Genentech, and is a member of Scientific Advisory Boards at Biogen, GlaxoSmithKline and Foresite Labs.Clinical TrialNCT04348240; NCT02327884; NCT04105569Funding StatementThese experiments were principally supported by grants and awards to K.M.B. (NIDCR K08 DE026537; AAP Sunstar Innovation Grant; L30 Loan Repayment Program for Clinical Researchers), and to B.M.W. (NIDCR Z01-DE000704) through the National Institutes of Health, National Institute of Dental and Craniofacial Research, Division of Intramural Research. Gingival scRNAseq was conducted by the UNC Advanced Analytics Core (Center for GI Biology and Disease; P30 DK034987). Additional support is from the Senior Research Training Fellowship by the American Lung Association (RT-575362), the Postdoctoral Research Fellowship by the Cystic Fibrosis Foundation (KATO20F0) to T.K, and NIH/NIDCR (K01DE027087 to J.T.M). The following investigators are also supported by the NIH Intramural Research Program: J.A.C., L.A.T., D.E.K., S.H., D.C., S.P., J.L.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies were conducted at two sites, independently utilizing clinical protocols which were approved by institutional review boards (IRB) at the respect institutions. UNC: Single cell gingival atlas constructed from human tissues was registered Clinicaltrials.gov ID: NCT04105569, approved by UNC IRB: 19-0183. Participant tissues included remnant oral specimens previously collected through the University of North Carolina Adams School of Dentistry Oral Pathology Biobank (UNC IRB 20-1501) or the Center for Oral and Systemic Diseases (COSD) Biorepository (UNC IRB 15-1814). Lab and project personnel were double-blinded and did not have access to PHI or any links to any PHI. Project members did not have interpersonal contact with patients that provided specimens. A subset of 10 samples from COVID-19 outpatients were collected (approved by UNC IRB 20-0792). The purpose of this study is to describe the epidemiology, clinical features, and immunological response to SARS-CoV-2 infection and develop new diagnostic tests focused on saliva. NIH: All patients seen at the author (B.M.W.) institute (NIDCR) reported herein provided informed consent prior to participation in NIH IRB-approved research protocols: NIH IRB 20-D-0094, NCT04348240; NIH IRB 15-D-0051, NCT02327884.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDATA AVAILABILITY: Unpublished human oral single cell datasets (minor salivary glands and oral mucosa) in this study can be visualized and assessed at www.covid19cellatlas.org. The published oral datasets from mice can accessed via the Chan Zuckerberg Biohub at https://tabulamuris.ds.czbiohub.org/ (dorsal tongue47) or via the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/) under the accession numbers GSE113466 (submandibular glands67), GSE131285 (parotid glands), and GSE120654 (buccal mucosa46). Human neutrophil data can be downloaded using the SRA Toolkit (SRP27137550) CODE AVAILABILITY: Analysis notebooks are available at github.com/Teichlab/covid19_oral. https://www.covid19cellatlas.org/ https://tabulamuris.ds.czbiohub.org/ https://www.ncbi.nlm.nih.gov/geo/ https://github.com/Teichlab/covid19_oral https://www.humancellatlas.org/publications/ http://software.10xgenomics.com/single-cell/overview/welcome https://satijalab.org/